Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03473795 · ClinicalTrials.gov registry record
Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes
A clinical trial of Non-Communicable Disease, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- 6,990
- Enrollment target
- 14
- Study locations
NCT03473795: Active study of Non-Communicable Disease, sponsored by Memorial Sloan Kettering Cancer Center.
NCT03473795 is a study of Non-Communicable Disease that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 6,990 participants. The trial reports 14 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03473795, a study of Non-Communicable Disease, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- 6,990 participants
- Enrollment target
- 14
- Study locations
Study Summary
This umbrella protocol seeks to develop robust data registries for non-communicable diseases (NCDs) in sub-Saharan Africa (SSA) with the aim of providing accurate and comprehensive data for the evaluation of such diseases in sub-Saharan African countries.Healthy volunteers will be included in the study for comparison. Additionally, the investigators aim to describe the gut microbiome community diversity of a cohort of community dwelling Nigerians and compare with CRC patients in Nigerian and at MSK. We will collect stool for microbiome and metabolomic analysis from community dwelling persons in the catchment area of ARGO facilities in Nigeria while contemporaneously administering an extensive medical and environmental exposure questionnaire.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire forms
- OTHER Bio-specimen samples
Study Locations (14)
Other
- University Of Nigeria Teaching Hospital (UNTH) Ituku-Ozalla Enugu - Enugu
- Lagos State University Teaching Hospital - Ikeja
- Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC) - Ile-Ife
- University of Ilorin Teaching Hospitals - Ilorin
- University of Maiduguri Teaching Hospital (Data collection only) - Maiduguri
- Ondo State Trauma and Surgical Centre - Ondo
- Federal Medical Centre Owo - Owo
Oyo State
- University College Hospital - Ibadan
- Ladoke Akintola University of Technology - Ogbomoso
New York
- Memorial Sloan Kettering Cancer Center - New York
Central Business District
- National Hospital of Abuja (Data collection only) - Abuja
Lagos
- Lagos State University Teaching Hospital - Idi Araba
Ogun State
- Olabisis Onabanjo University Teaching Hospital - Sagamu
Ondo State
- Federal Medical Centre Owo - Owo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,990 participants |
| Start Date | 2018-03-16 |
| Est. Completion | 2027-03 |
What the registry record for NCT03473795 still lists
NCT03473795 is an observational study that tracks outcomes without assigning an intervention. Its 6,990 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Non-Communicable Disease appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire forms is the first listed.
NCT03473795 lists 14 locations in 7 states (Other, Oyo State, New York).
Frequently Asked Questions
What is clinical trial NCT03473795 about?
NCT03473795 is a clinical study titled "Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes". This umbrella protocol seeks to develop robust data registries for non-communicable diseases (NCDs) in sub-Saharan Africa (SSA) with the aim of providing accurate and comprehensive data for the evaluation of such diseases in sub-Saharan African countries.Healthy volunteers will be included in the st...
What is the current status of trial NCT03473795?
This trial is currently active not recruiting. The enrollment target is 6,990 participants. The study started on 2018-03-16. Estimated completion is 2027-03.
What conditions does trial NCT03473795 study?
This clinical trial studies the following conditions: Non-Communicable Disease.
What interventions are being tested in trial NCT03473795?
The interventions under investigation include: Questionnaire forms (BEHAVIORAL), Bio-specimen samples (OTHER).
Who is sponsoring clinical trial NCT03473795?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03473795 being conducted?
This trial has 14 study locations across New York, Central Business District, Lagos, Ogun State, Ondo State. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00260585 · 7,000 participants
Esophageal Cancer Risk Registry
- NCT04118660 · 7,000 participants
Thoracic Specimen Registry
- NCT07106879 · 7,000 participants
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.
- NCT07140744 · 7,000 participants · NA
A Study Evaluating the Impact of P-tau217 Blood Biomarker Testing on Early Evaluation and Management of Patients Presenting With Cognitive Complaint
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI